INDV: Indivior PLC Stock

by  •  • Comments Off on INDV: Indivior PLC Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,130.32
Enterprise Value ($M) 1,144.32
Book Value ($M) -205.00
Book Value / Share -1.64
Price / Book -5.51
NCAV ($M) -842.00
NCAV / Share -6.75
Price / NCAV -1.34

Profitability (mra)
Return on Invested Capital (ROIC) -0.28
Return on Assets (ROA) -0.03
Return on Equity (ROE) -4.80

Liquidity (mrq)
Quick Ratio 0.69
Current Ratio 0.88

Balance Sheet (mrq) ($M)
Current Assets 829.00
Assets 1,466.00
Liabilities 1,671.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,188.00
Operating Income 256.00
Net Income -48.00

Cash Flow Statement (mra) ($M)
Cash From Operations 21.00
Cash from Investing 69.00
Cash from Financing -87.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
03-18 13G Madison Avenue Partners, LP 6.00
03-04 13D/A Oaktree Capital Holdings, LLC 8.60 12.54
03-04 13D/A Two Seas Capital LP 9.30 -3.56
02-13 13G/A Flynn James E 7.16 20.64
11-14 13G/A Scopia Capital Management Lp 4.30 -51.80
2024-04-09 13G SG Americas Securities, LLC 5.17

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 68,581 1,383,532 4.96
2025-04-16 49,933 694,771 7.19
2025-04-15 93,443 773,163 12.09
2025-04-14 148,138 708,127 20.92

(click for more detail)

Similar Companies
IMUX – Immunic, Inc. IMVT – Immunovant, Inc.
INBX – Inhibrx Biosciences, Inc. INNV – InnovAge Holding Corp.
INSM – Insmed Incorporated


Financial data and stock pages provided by
Fintel.io